Cardiac Mapping Market 2022 Key Players Data and Industry Analysis.2030
.jpg){kind=logo}
Cardiac
Mapping Market Overview
In the last ten years, interventional electrophysiology has
advanced dramatically. Cardiac mapping is one of the most sophisticated methods
for collecting and displaying information from an ECG. It's defined as a method
for determining the spatial and temporal distribution of cardiac electrical
signals during a specific heart beat. The data is sent to the software, which
creates a three-dimensional (3D) model of the heart, displaying the
electromagnetic waves generated during each beating. The approach reveals the
catheter's position and movement inside the heart. Cardiac mapping is a simple
process that allows doctors to locate the location of heart chambers that are
suffering arrhythmia. The cardiac mapping market is expected to
reach USD 1179.81 Million by 2030 at 8.20% CAGR during the forecast period
2022-2030.
New entrants into the market, increased investments, funding, and
grants, increasing incidence of target diseases, and growth in the geriatric
population are all driving factors in the cardiac mapping industry's growth.
Increased funding and grants for research and development efforts in cardiac
mapping technology, rising prevalence of target diseases, and a growing
geriatric population are all major drivers propelling the Cardiac Mapping
Market forward. The rise in the incidence of cardiovascular diseases
among all age groups as a result of a sedentary lifestyle and obesity, as well
as the involvement of key companies such as Abbott and Medtronic in the
manufacturing of contact mapping systems, are expected to boost the market's
growth during the forecast period.
Several advanced diagnostic technologies introduced by medical
device companies, increased demand for precise diagnosis of critical cardiac
diseases, and the availability of well-qualified interventional cardiologists
in developed economies are expected to boost the growth of the cardiac mapping
systems market over the forecast period.
However, in the near future, lack of awareness about cardiac
mapping systems in underdeveloped countries, their high cost, and the risks
associated with cardiac mapping procedures are expected to be major restraints
of the cardiac mapping systems market. Furthermore, due to macroeconomic
disruptions caused by the COVID-19 pandemic, there will be significant changes
in the product pipeline and entire supply chain. As a result of the eruption,
government officials are increasingly concerned about residents' and healthcare
personnel' health and safety. Furthermore, several regulatory agencies and
governments have created a slew of different safety requirements. When COVID-19
cases start to decline, other chronic diseases will once again become a priority.
These reasons suggest that the cardiac mapping market will continue to grow in
the future.
Market Segmentation
The Global Cardiac Mapping Market is divided into three
categories: product, indication, and end user.
The market has been segmented into two categories based on
product: contact cardiac mapping systems and non-contact cardiac mapping
systems. Because of its widespread availability, contact cardiac mapping
devices are expected to have the largest market share in the worldwide cardiac
mapping industry.
Atrial fibrillation, atrial flutter, atrioventricular nodal
reentrant tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), and other
indications have been divided into the cardiac mapping market. Because of the
significant number of individuals who suffer from atrial fibrillation, the
sector is expected to have the biggest market share.
Hospitals, clinics, diagnostic centers, and others are among the
end user categories of market. As these are the principal places where patients
obtain diagnosis and treatment, hospitals are likely to hold the highest share
of the market. Due to the high frequency of cardiac arrhythmias and the growing
awareness of them in emerging nations, the segment is likely to continue its
leadership position during the projected period.
Regional Overview
In terms of regions, cardiac mapping is expected to be the most
popular during the projected period in North America. The major factors driving
the North American market are an increase in the approval rate of mapping
systems and clinical trials validating cardiac mapping systems in the United
States, a high incidence of CVDs, a growing focus of government organizations
on providing funding for research, and an increasing geriatric population in
Canada. The market will be driven by the flexible management of patients in US
hospitals and attractive reimbursement policies for cardiovascular disorders.
Because of the integration of technology and health care in North American
health care facilities, the area is likely to remain dominating during the
projected period.
During the projection period, Europe and Asia-Pacific are also
likely to provide profitable prospects. In India and Australia, the number of
interventional cardiologists is expanding, raising knowledge of cardiac mapping
devices in those nations. This is thought to be a key element in the market's
projected expansion in Asia Pacific at a comparatively high CAGR during the
forecast period.
Competitive Dynamics
Cardiac
Mapping Market players are Abbott Laboratories, GE Healthcare,
Boston Scientific Corporation, Medtronic plc., Johnson & Johnson,
Koninklijke Philips N.V., Hill-Rom Services, Inc., and others.
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality market
research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment